
Validea's Price/Sales Investor model, based on Kenneth Fisher's strategy, has upgraded ACME UNITED CORP (ACU) from a 50% to a 90% rating, indicating strong interest driven by improved underlying fundamentals and valuation. The small-cap growth stock, a supplier of first aid and cutting products, passed most of the strategy's criteria, including low P/S, strong free cash flow, and consistent profit margins, though it notably failed on long-term EPS growth, suggesting a potential re-evaluation point for institutional investors.
Acme United Corp. (ACU) has received a significant rating upgrade from 50% to 90% within Validea's quantitative model based on Kenneth Fisher's Price/Sales Investor strategy, signaling strong interest from the framework. This upgrade for the small-cap supplier is rooted in its strong performance on key value metrics, including a favorable Price/Sales ratio, a manageable Total Debt/Equity ratio, strong Free Cash Flow per Share, and a consistent three-year average net profit margin. These factors align with the core tenets of the Fisher strategy, which prioritizes undervalued companies with solid financial health. However, a critical point of divergence is the stock's failure to meet the model's criterion for Long-Term EPS Growth Rate. This specific weakness presents a notable contradiction for a stock categorized in the growth segment and warrants deeper investigation, as it suggests that while the current valuation is attractive, the trajectory of future earnings may be a point of concern.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment